Advertisement

Advertisement

DE:7JK Stock Latest News

EQL Pharma CEO Sells Small Stake to Cover Tax From Option Redemption

Company AnnouncementsEQL Pharma CEO Sells Small Stake to Cover Tax From Option Redemption

EQL Pharma Wins Italian Approval for Melatonin Drug Mellozzan

PremiumCompany Announcements

EQL Pharma Wins Italian Approval for Melatonin Drug Mellozzan

15d ago

EQL Pharma Names Nomination Committee Ahead of 2026 AGM

PremiumCompany Announcements

EQL Pharma Names Nomination Committee Ahead of 2026 AGM

2M ago

EQL Pharma Launches New Warrant-Based Incentive Programme for Key Employees

PremiumCompany Announcements

EQL Pharma Launches New Warrant-Based Incentive Programme for Key Employees

2M ago

EQL Pharma Posts Record Quarter as European Expansion and Pipeline Drive Growth

PremiumCompany Announcements

EQL Pharma Posts Record Quarter as European Expansion and Pipeline Drive Growth

2M ago

7JK Earnings this Week: How Will it Perform?

PremiumPre-Earnings7JK Earnings this Week: How Will it Perform?

2M ago

EQL Pharma to Present Q3 2025/26 Interim Report in February

Company Announcements

EQL Pharma to Present Q3 2025/26 Interim Report in February

3M ago

EQL Pharma Calls EGM to Approve New Executive Warrant Incentive Scheme

Company Announcements

EQL Pharma Calls EGM to Approve New Executive Warrant Incentive Scheme

3M ago

EQL Pharma Strengthens Leadership for European Expansion

PremiumCompany Announcements

EQL Pharma Strengthens Leadership for European Expansion

4M ago

EQL Pharma Appoints New CFO to Drive Growth and Expansion

PremiumCompany Announcements

EQL Pharma Appoints New CFO to Drive Growth and Expansion

4M ago

EQL Pharma AB Moves Bonds to Nasdaq Stockholm’s Corporate Bond List

PremiumCompany Announcements

EQL Pharma AB Moves Bonds to Nasdaq Stockholm’s Corporate Bond List

5M ago

EQL Pharma Gains Approval for Cystohipp in Germany

PremiumCompany Announcements

EQL Pharma Gains Approval for Cystohipp in Germany

5M ago

7JK Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings7JK Earnings Report this Week: Is It a Buy, Ahead of Earnings?

5M ago

EQL Pharma Faces Challenges Amid Growth Plans

Company Announcements

EQL Pharma Faces Challenges Amid Growth Plans

5M ago

EQL Pharma AB to Present Interim Report for Q2 2025/26

Company Announcements

EQL Pharma AB to Present Interim Report for Q2 2025/26

6M ago

EQL Pharma AB Seeks New CCO Amid Strategic Transition

PremiumCompany Announcements

EQL Pharma AB Seeks New CCO Amid Strategic Transition

6M ago

EQL Pharma Expands Melatonin Product Mellozzan® to UK Market

PremiumCompany Announcements

EQL Pharma Expands Melatonin Product Mellozzan® to UK Market

7M ago

EQL Pharma Faces Temporary Setbacks Due to Delivery Delays

PremiumCompany Announcements

EQL Pharma Faces Temporary Setbacks Due to Delivery Delays

7M ago

EQL Pharma’s Mellozzan® Gains Approval in Turkey, Expanding Market Reach

PremiumCompany Announcements

EQL Pharma’s Mellozzan® Gains Approval in Turkey, Expanding Market Reach

7M ago

EQL Pharma AB Executives Exercise Warrants, Boosting Capital

PremiumCompany AnnouncementsEQL Pharma AB Executives Exercise Warrants, Boosting Capital

7M ago

EQL Pharma CCO Sells Shares for Personal Reasons

Company Announcements

EQL Pharma CCO Sells Shares for Personal Reasons

8M ago

EQL Pharma AB’s Annual General Meeting Resolutions and New Incentive Program

Company Announcements

EQL Pharma AB’s Annual General Meeting Resolutions and New Incentive Program

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >